Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
$6.01
-0.350 (-5.50%)
At Close: May 10, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $5.84 $8.40 Friday, 10th May 2024 VERV stock ended at $6.01. This is 5.50% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 9.35% from a day low at $5.88 to a day high of $6.43.
90 days $5.84 $19.34
52 weeks $5.84 $21.42

Historical Verve Therapeutics, Inc. prices

Date Open High Low Close Volume
Jun 21, 2022 $13.04 $14.12 $13.00 $13.03 705 833
Jun 17, 2022 $11.76 $12.86 $11.59 $12.65 4 579 326
Jun 16, 2022 $11.64 $12.13 $10.70 $11.14 857 099
Jun 15, 2022 $11.81 $12.51 $11.32 $12.29 584 565
Jun 14, 2022 $12.04 $12.55 $10.77 $11.71 725 684
Jun 13, 2022 $12.01 $12.51 $11.50 $11.84 880 311
Jun 10, 2022 $13.68 $13.96 $12.45 $12.61 872 542
Jun 09, 2022 $14.80 $14.88 $13.95 $14.04 400 913
Jun 08, 2022 $14.68 $15.85 $14.37 $15.00 541 966
Jun 07, 2022 $13.37 $14.81 $13.27 $14.72 430 058
Jun 06, 2022 $14.96 $15.24 $13.40 $13.54 622 187
Jun 03, 2022 $14.39 $14.68 $14.11 $14.58 525 439
Jun 02, 2022 $14.28 $14.62 $13.80 $14.41 326 766
Jun 01, 2022 $15.26 $15.61 $14.15 $14.44 581 322
May 31, 2022 $15.52 $15.72 $14.67 $15.16 664 601
May 27, 2022 $14.16 $15.92 $13.99 $15.65 689 235
May 26, 2022 $13.50 $14.78 $13.28 $14.01 631 601
May 25, 2022 $13.27 $14.16 $12.76 $13.52 596 972
May 24, 2022 $13.58 $13.70 $13.22 $13.34 566 207
May 23, 2022 $13.28 $14.15 $13.13 $13.93 563 684
May 20, 2022 $13.76 $13.77 $12.59 $13.41 509 597
May 19, 2022 $13.47 $14.04 $13.12 $13.54 696 083
May 18, 2022 $13.64 $14.19 $13.21 $13.61 553 877
May 17, 2022 $14.29 $14.43 $13.79 $14.25 506 892
May 16, 2022 $13.98 $15.28 $13.68 $13.79 500 712
Click to get the best stock tips daily for free!

About Verve Therapeutics, Inc.

Verve Therapeutics. Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program to permanently turn off the ANGPTL3 gene in the liver. It has a collaboration and license agreement with... VERV Profile

Golden Star

Ticker Date Change Price
SXI May 08 2.97% $173.34
NVO May 08 1.37% $126.69
PAG May 07 1.42% $153.22
WMT May 06 1.02% $59.87
UNP May 06 3.42% $239.21
JPM May 06 3.53% $192.00
INGR May 03 4.94% $114.56
ASH May 03 2.28% $95.85
INVH May 03 1.13% $34.39
INTU May 03 0.483% $629.27
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT